Meloxicam and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Neupogen (filgrastim). Common drug interactions include muscular weakness among females and acute generalised exanthematous pustulosis among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Neupogen. It is created by eHealthMe based on reports of 84 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 20, 2026

84 people who take Meloxicam and Neupogen together, and have interactions are studied.

Meloxicam and Neupogen drug interactions.

What are the common drug interactions of Meloxicam and Neupogen, by gender? *:

female:

Muscular weakness (muscle weakness)
Neck injury
Oedema peripheral (superficial swelling)
Oesophageal mucosal hyperplasia (increased mucous membrane cells of oesophagus)
Oral fibroma (fibrous growths of the oral soft tissues)
Oral mucosa atrophy (mucous membrane wasting of mouth)
Pain in jaw
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Periodontal disease (disease that attacks the gum and bone and around the teeth)
Plasmacytosis (presence of lots of plasma cells in bone or other tissues)

male:

Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
White blood cell count decreased
Haematocrit decreased
Oropharyngeal pain
Blood culture positive
Pustular psoriasis (raised bumps on the skin that are filled with pus)
Depression
Red blood cell count decreased
Anaemia (lack of blood)

What are the common drug interactions of Meloxicam and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Back pain
Dyspnoea (difficult or laboured respiration)
Emotional distress
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Abdominal pain
Abdominal pain upper
Actinomycosis (infection that causes sores, or abscesses)

50-59:

Oesophageal mucosal hyperplasia (increased mucous membrane cells of oesophagus)
Oral fibroma (fibrous growths of the oral soft tissues)
Oral mucosa atrophy (mucous membrane wasting of mouth)
Pain in jaw
Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
Periodontal disease (disease that attacks the gum and bone and around the teeth)
Plasmacytosis (presence of lots of plasma cells in bone or other tissues)
Polyuria (production of too much dilute urine)
Postmenopausal haemorrhage (post-menopausal bleeding)
Pruritus (severe itching of the skin)

60+:

Acute generalised exanthematous pustulosis (acute febrile drug eruption)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Lethargy (tiredness)
Oropharyngeal pain
Pustular psoriasis (raised bumps on the skin that are filled with pus)
White blood cell count decreased
Death
Rash
Confusional state

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 37 people, 44.05%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 22.62%
High Blood Pressure: 16 people, 19.05%
Fatigue (feeling of tiredness): 16 people, 19.05%
Pain: 13 people, 15.48%
Nausea (feeling of having an urge to vomit): 13 people, 15.48%
High Blood Cholesterol: 9 people, 10.71%
Cough: 6 people, 7.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 7.14%
Neuropathy Peripheral (surface nerve damage): 5 people, 5.95%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously